New Novo Nordisk insulin not recommended for approval by FDA expert panel
On Friday, an expert panel under the US Food and Drug Administration (FDA) had bad news for Novo Nordisk regarding its weekly insulin Awiqli.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.